Skip to main content
. 2018 Feb 27;9(5):137–150. doi: 10.1177/2042018818759894

Figure 5.

Figure 5.

Serum levels in study cohort. (a) Serum FABP4 was measured by ELISA following manufacturer’s standard protocol for the groups; well- (n = 16), poorly controlled (n = 15) type 2 diabetes patients and healthy controls (n = 20). Results are expressed as mean ± SEM (p < 0.01, one-way ANOVA followed by Holm–Sidak multiple comparisons test); *p < 0.05, **p < 0.01 compared against control. Cytokines were quantified using flow cytometry-based bead arrays following manufacturer’s protocol. Serum from poorly controlled diabetic (n =15), well-controlled diabetic (n = 16) and control (n = 20) subjects was assessed for Th1/Th2 and obesity-related markers. (b) Resistin (c) leptin. Results presented as a box plot (min–max) (p < 0.001 Kruskal–Wallis one-way ANOVA for both resistin and leptin levels, followed by Dunn’s post-test corrected for multiple comparisons). (d) Cytokines levels in the groups (mean ± SEM) [Kruskal–Wallis one-way ANOVA, *p < 0.05, **p < 0.01 (compared against control, Dunn’s post-test corrected for multiple comparisons)].